ArticleMedical oncology (Northwood, London, England)2018
Biomarkers defining probability of receiving second-line targeted therapy in metastatic renal cell carcinoma.
Pawel Chrom et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.